A strong value proposition is no longer enough. Growth depends on understanding the people, pressures, proof and internal alignment required for an organization to act.
Executive answer
Why do strong go-to-market opportunities stall?
Strong opportunities often stall because the buying coalition, risk requirements or internal decision process has changed. The sponsor may value the solution but lack the authority, evidence or cross-functional support needed to move the organization forward.
The challenge
Many go-to-market models still assume a linear buyer journey. In life sciences, decisions increasingly involve business, medical, access, procurement, finance, technology, security, legal and executive stakeholders—each with a different definition of value and risk.
Where RISE focuses
RISE helps teams move from stakeholder lists to decision architecture.
- Market, buyer and account strategy
- Positioning and commercial narrative
- Buying-coalition and decision mapping
- Growth activation and pipeline movement
How the work moves
We clarify who recognizes the problem, who owns the outcome, who controls resources, who evaluates risk and what each person needs to believe. Then we equip the internal champion to create a shared case for action.
What better looks like
- A sharper ideal-customer focus
- More relevant executive conversations
- Clearer opportunity qualification
- A credible path to collective commitment
Frequently asked questions
What is decision architecture?
Decision architecture maps the people, requirements, dependencies and beliefs that must align before an organization can commit—not simply the visible decision-maker.
How is this different from stakeholder mapping?
Stakeholder mapping identifies who is involved. Decision architecture explains how the decision moves, where it can stop and what must become true for each participant.
Can RISE help a life sciences solution provider?
Yes. RISE helps solution providers translate capability into an industry-relevant narrative, reach the right leaders and navigate complex enterprise buying decisions.
Start a focused conversation
What consequential decision is in front of your organization?
carl@therisegroup.ai